Vimarsana
Biggest News Aggregation in the World

Page 46 - Self Test News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Self Test. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Self Test Today - Breaking & Trending Today

Walgreens, Walmart and CVS to sell COVID-19 tests on shelves, online in next few days - Vimarsana News

Walgreens, Walmart and CVS to sell COVID-19 tests on shelves, online in next few days

Walgreens, Walmart and CVS to sell COVID-19 tests on shelves, online in next few days Rapid COVID-19 tests at home and last updated 2021-04-21 22:10:17-04 VIRGINIA BEACH, Va. - Walgreens, Walmart and CVS drug stores all say COVID-19 tests will be available on their shelves and online in the next few days. They said they have different variations of the COVID-19 test. CVS leaders said tests include the Ellume COVID-19 Home Test, the Abbott BinaxNOW COVID-19 Antigen Self Test and the Pixel by Labcorp PCR Test Home Collection Kit. They said all three tests have received FDA Emergency Use Author...

Source: wtkr.com
CVS Announces the Availability of Over-the-Counter COVID-19 Tests - Vimarsana News

CVS Announces the Availability of Over-the-Counter COVID-19 Tests

Author Bio Eric has been writing about stocks and finance since the mid-1990s, when he lived in Prague, Czech Republic. Over the course of a varied career, he has also been a radio newscaster, an investment banker, and a bass player in a selection of rock and roll bands. A native New Yorker, he currently lives in Los Angeles. CVS Health (NYSE:CVS) said on Monday that its stores have begun carrying three over-the-counter COVID-19 tests. The products -- the Ellume COVID-19 Home Test, Abbott Laboratories' BinaxNOW Antigen Self Test, and the Pixel by Labcorp PCR Test Hom...

Source: fool.com
Abbott Reports First-Quarter 2021 Results - Vimarsana News

Abbott Reports First-Quarter 2021 Results

Share this article Share this article ABBOTT PARK, Ill., April 20, 2021 /PRNewswire/ -- Abbott (NYSE: ABT) today announced financial results for the first quarter ended March 31, 2021. First-quarter sales of $10.5 billion increased 35.3 percent on a reported basis and 32.9 percent on an organic basis, which excludes the impact of foreign exchange. First-quarter GAAP diluted EPS was $1.00 and adjusted diluted EPS, which excludes specified items, was $1.32, reflecting 103.1 percent growth versus the prior year. 1 Abbott projects full-year 2021 diluted EPS from continuing operations on a GAAP...

CVS Pharmacy Offers Over-the-counter COVID-19 Testing Options - Vimarsana News

CVS Pharmacy Offers Over-the-counter COVID-19 Testing Options

CVS Pharmacy Offers Over-the-counter COVID-19 Testing Options WOONSOCKET (dpa-AFX) - CVS Pharmacy, the retail division of CVS Health, announced the availability of three over-the-counter or OTC COVID-19 testing options in stores and online. With these new-to-market home tests, customers will get access to convenient testing that can be conducted at home. The tests include the Ellume COVID-19 Home Test, the Abbott BinaxNOW COVID-19 Antigen Self Test and the Pixel by Labcorp PCR Test Home Collection Kit. All three tests have received Emergency Use Authorization or EUA from the U.S. Food and Dru...

Abbott's Sales Soared in Q1, but Not Enough to Satisfy Wall Street - Vimarsana News

Abbott's Sales Soared in Q1, but Not Enough to Satisfy Wall Street

Author Bio Keith began writing for the Fool in 2012 and focuses primarily on healthcare investing topics. His background includes serving in management and consulting for the healthcare technology, health insurance, medical device, and pharmacy benefits management industries. Follow @keithspeights Abbott Laboratories (NYSE:ABT) entered 2020 as a strong and growing business. Then the COVID-19 pandemic hit, and the company became even stronger, with much faster growth.  The healthcare giant announced its first-quarter results before the market opened on Tuesday. Here ar...

Source: fool.com